William Blair’s biopharma investment banking team’s Quarterly Rx was cited by the The Wall Street Journal in its coverage of IPO activity and other investment trends in the sector.
Investment Banking
The Wall Street Journal Cites Biopharma Investment Banking’s Quarterly Report
Delivered to Your Inbox
Stay up-to-date with the latest William Blair news and insights
Our Latest News
-
William Blair Adds Senior Banker in London With Focus on Consumer Products & Services
William Blair has announced the addition of Chris Bates as director in the firm’s Consumer Products & Services group in London. Bates will provide comprehensive advisory support to European beauty, personal care, and consumer-health companies.
-
-
William Blair Advises ENTEK and Endeavour Capital
William Blair acted as exclusive financial advisor to ENTEK Technology Holdings LLC, a portfolio company of Endeavour Capital, in connection with today’s announcement that I Squared Capital has agreed to acquire a majority equity interest in the company.